| Marta C Kolthoff, MD | |
|
4815 Liberty Avenue, Suite Gr59, Pittsburgh, PA 15224-2156 | |
| (412) 578-3951 | |
| (412) 578-1587 |
| Full Name | Marta C Kolthoff |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 4815 Liberty Avenue, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598719767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD419735 (Pennsylvania) | Secondary |
| 207SG0201X | Medical Genetics - Clinical Genetics (m.d.) | MD419735 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Clinic | 5395649586 | 1941 |
News Archive
An inexpensive and rapid test for tuberculosis (TB) which could be used in developing countries has won first place in the Best Innovation to Improve Global Healthcare category of the Medical Futures Innovation Awards. It also scooped the overall prize at the awards ceremony held last week in London.
SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced the opening of its two newest facilities, Daoli Fitness and Legend Spa Central Club. Both centers, which, as previously announced, have been engaged in pre-opening activities for several months, are located in the Long Dian Building in downtown Harbin, China, a centrally located building for SOKO's target upper-middle class clients.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
Meanwhile, on the House side, the Energy and Commerce Committee approved legislation that would allow people with group health insurance to keep policies that don't conform to the health law's standards.
› Verified 3 days ago
| Entity Name | St Vincent Medical Education And Research Institute Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902881477 PECOS PAC ID: 3870405137 Enrollment ID: O20031104000576 |
News Archive
An inexpensive and rapid test for tuberculosis (TB) which could be used in developing countries has won first place in the Best Innovation to Improve Global Healthcare category of the Medical Futures Innovation Awards. It also scooped the overall prize at the awards ceremony held last week in London.
SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced the opening of its two newest facilities, Daoli Fitness and Legend Spa Central Club. Both centers, which, as previously announced, have been engaged in pre-opening activities for several months, are located in the Long Dian Building in downtown Harbin, China, a centrally located building for SOKO's target upper-middle class clients.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
Meanwhile, on the House side, the Energy and Commerce Committee approved legislation that would allow people with group health insurance to keep policies that don't conform to the health law's standards.
› Verified 3 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
An inexpensive and rapid test for tuberculosis (TB) which could be used in developing countries has won first place in the Best Innovation to Improve Global Healthcare category of the Medical Futures Innovation Awards. It also scooped the overall prize at the awards ceremony held last week in London.
SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced the opening of its two newest facilities, Daoli Fitness and Legend Spa Central Club. Both centers, which, as previously announced, have been engaged in pre-opening activities for several months, are located in the Long Dian Building in downtown Harbin, China, a centrally located building for SOKO's target upper-middle class clients.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
Meanwhile, on the House side, the Energy and Commerce Committee approved legislation that would allow people with group health insurance to keep policies that don't conform to the health law's standards.
› Verified 3 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
An inexpensive and rapid test for tuberculosis (TB) which could be used in developing countries has won first place in the Best Innovation to Improve Global Healthcare category of the Medical Futures Innovation Awards. It also scooped the overall prize at the awards ceremony held last week in London.
SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced the opening of its two newest facilities, Daoli Fitness and Legend Spa Central Club. Both centers, which, as previously announced, have been engaged in pre-opening activities for several months, are located in the Long Dian Building in downtown Harbin, China, a centrally located building for SOKO's target upper-middle class clients.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
Meanwhile, on the House side, the Energy and Commerce Committee approved legislation that would allow people with group health insurance to keep policies that don't conform to the health law's standards.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marta C Kolthoff, MD 4815 Liberty Avenue, Suite Gr59, Pittsburgh, PA 15224-2156 Ph: (412) 578-3951 | Marta C Kolthoff, MD 4815 Liberty Avenue, Suite Gr59, Pittsburgh, PA 15224-2156 Ph: (412) 578-3951 |
News Archive
An inexpensive and rapid test for tuberculosis (TB) which could be used in developing countries has won first place in the Best Innovation to Improve Global Healthcare category of the Medical Futures Innovation Awards. It also scooped the overall prize at the awards ceremony held last week in London.
SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced the opening of its two newest facilities, Daoli Fitness and Legend Spa Central Club. Both centers, which, as previously announced, have been engaged in pre-opening activities for several months, are located in the Long Dian Building in downtown Harbin, China, a centrally located building for SOKO's target upper-middle class clients.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
Meanwhile, on the House side, the Energy and Commerce Committee approved legislation that would allow people with group health insurance to keep policies that don't conform to the health law's standards.
› Verified 3 days ago